References
- Borowitz DS, Grand RJ, Durie PR. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. J Pediatr 1995; 127:681–4.
- Walkowiak J, Herzig KH, Witt M, Pogorzelski A, Piotrowski R, Barra E, et al. Analysis of exocrine pancreatic function in cystic fibrosis: one mild CFTR mutation does not exclude pancreatic insufficiency. Eur J Clin Invest 2001;1:796–801.
- Walkowiak J, Herzig KH. Fecal elastase-1 is decreased in villous atrophy regardless of underlying disease. Eur J Clin Invest 2001; 31:425–30.
- Farthing MJG. The molecular pathogenesis of giardiasis. J Pediatr Gastroenterol Nutr 1997;24:79–88.
- Roberts DM, Craft JC, Mather FJ, Davis SH, Wright JA, Jr. Prevalence of giardiasis in patients with cystic fibrosis. J Pediatr 1998;112:555–9.
- Oberhuber G, Kastner N, Stolte M, Giardiasis. A histologic analysis of 567 cases. Scand J Gastroenterol 1997;32:48–51.